This company is no longer active
Vallon Pharmaceuticals Bilan de santé
Santé financière contrôle des critères 4/6
Vallon Pharmaceuticals has a total shareholder equity of $2.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.2M and $1.8M respectively.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$3.78m |
| Fonds propres | US$2.34m |
| Total du passif | US$1.81m |
| Total des actifs | US$4.15m |
Mises à jour récentes de la santé financière
We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate
Dec 15
We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully
Aug 17Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?
May 17Recent updates
Analyse de la situation financière
Passif à court terme: VLON's short term assets ($4.2M) exceed its short term liabilities ($1.8M).
Passif à long terme: VLON has no long term liabilities.
Historique et analyse du ratio d'endettement
Niveau d'endettement: VLON is debt free.
Réduire la dette: VLON had no debt 5 years ago.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: VLON has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: VLON has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.5% each year